News Blog
Linda Tannenbaum, OMF Founder and CEO/President, will join the leading U.S. ME/CFS experts as they convene for the Second Annual ME/CFS Clinician Summit on March 15-16 in Salt Lake City, Utah. This event is significant because it marks progress and forward momentum for this dedicated group as they tackle the ambitious goal of mainstreaming ME/CFS in...
When we announced the Hope & Heart Unite for ME/CFS Poetry & Art Slam project together with Lev Leytzan, we said, “Your words and art have power.” The heart and hope shared in your words and images truly left us speechless. We thank each and every person who submitted a heartfelt entry. You have truly touched...
We want to thank again Emerge Australia for hosting the International Research Symposium on ME/CFS. Along with leading international researchers, OMF-funded researchers including Scientific Advisory Board Director Ronald W. Davis, PhD, Jonas Bergquist, MD, PhD, Wenzhong Xiao, PhD, Robert Phair, PhD, and Christopher Armstrong, PhD, will be presenting. Emerge has just announced that the...
Gary Burgess, UK reporter, has interviewed Linda Tannenbaum, OMF Founder & CEO/President, for his podcast, The ME Show. This new podcast is supported by the ME Association UK. In this podcast Linda reviews the history of OMF, our research focus, and shares a message of HOPE for all. Listen to The ME Show episode featuring Linda...
On behalf of our OMF Team, including our Board of Directors, Scientific Advisory Board, and patients around the world, thank you for your impactful support helping to make 2018 a banner year in ME/CFS research. With more than $9 million raised in 2018, we are able to accelerate our efforts to engage more researchers and...
As promised, below is the link to the complete version of the Red Blood Cell (RBC) Deformability research paper, which has now been formally published, open source, in Clinical Hemorheology and Microcirculation. The authors are Mohsen Nemat-Gorgani, PhD, of Stanford University, and Anand Ramasubramanian, PhD, of San Jose State University, in collaboration with Ron Davis, PhD, and their teams. This important...
As this year comes to an end, I would like to take a moment to express my gratitude to those who have helped us to advance research to end ME/CFS. With your support, we are making important strides towards understanding ME/CFS. This year we have made positive progress and we won’t stop until a cure is found!...
Written by Ronald W. Davis, PhD This paper documents that red blood cells are less deformable in ME/CFS patients compared to healthy controls. It potentially could be a biomarker, and we are proceeding to design new devices that will make a clear distinction between patients and healthy controls. These devices will be hand-held and easy...
At the three-day Working Group Meeting and Community Symposium on the Molecular Basis of ME/CFS at Stanford University, sponsored by OMF, so much scientific progress was evident. We are clearly progressing from just data gathering to formulating new hypotheses as to the causes of symptoms and even a possible cause of the disease. The buzz...
